Interleukin(IL)-4 and IL-4 receptors in regulation of type 2 immune responses
Description of the granted funding
Immune response protects us against invading pathogens; viruses, bacteria, parasites and yeasts. Inappropriately activated immune response can result in autoimmune reaction or allergic reaction. Humoral mediators, cytokines, are critical regulators of various immune responses. This study clarifies, how cytokines especially Interleukin(IL)-4 regulates allergic inflammation. By understanding how IL-4 and its cell surface receptors function, its' therapeutical utilization, for example in autoimmune diseases to redirect immune response to less inflammatory direction may become possible. In this study, we utilize genetically modified knockout and transgenic mice (some of which are unpublished), clinical samples and cell culture models. The study is collaborative project between, TaY, TAYS, Fimlab Inc and NIH (USA) and is based on my previous research (Junttila I et al., J. Exp Med., 2008, Junttila I et al. Nat Chem Biol., 2012, Junttila I et al. J Allergy Clin Immunol., 2013).
Show moreStarting year
2017
End year
2022
Granted funding
Related funding decisions
314204
Research costs of Academy Research Fellows(2017)
64 800 €
335742
Research costs of Academy Research Fellows(2020)
200 845 €
326380
Research costs of Academy Research Fellows(2019)
260 287 €
326379
Academy research fellows(2019)
333 696 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
308048
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
biotechnology, biomedicine